135 related articles for article (PubMed ID: 22342137)
21. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
[TBL] [Abstract][Full Text] [Related]
22. The effect of the length of the prodromal period on the metabolic control within the first 2 years in children with diabetic ketoacidosis manifestation.
Murat Z; Arica V; Dogan M; Arica SG
J Pediatr Endocrinol Metab; 2011; 24(9-10):659-63. PubMed ID: 22145452
[TBL] [Abstract][Full Text] [Related]
23. Glycaemic control and antibody status among patients with newly diagnosed Type 1 diabetes.
Hickey D; Joshy G; Dunn P; Simmons D; Lawrenson R
N Z Med J; 2007 Sep; 120(1262):U2732. PubMed ID: 17891220
[TBL] [Abstract][Full Text] [Related]
24. Poor Metabolic Control in Children and Adolescents With Type 1 Diabetes and Psychiatric Comorbidity.
Sildorf SM; Breinegaard N; Lindkvist EB; Tolstrup JS; Boisen KA; Teilmann GK; Skovgaard AM; Svensson J
Diabetes Care; 2018 Nov; 41(11):2289-2296. PubMed ID: 30270201
[TBL] [Abstract][Full Text] [Related]
25. Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes.
Sassa M; Yamada Y; Hosokawa M; Fukuda K; Fujimoto S; Toyoda K; Tsukiyama K; Seino Y; Inagaki N
Diabetes Res Clin Pract; 2008 Aug; 81(2):190-5. PubMed ID: 18514964
[TBL] [Abstract][Full Text] [Related]
26. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
Stene LC; Barriga K; Hoffman M; Kean J; Klingensmith G; Norris JM; Erlich HA; Eisenbarth GS; Rewers M
Pediatr Diabetes; 2006 Oct; 7(5):247-53. PubMed ID: 17054445
[TBL] [Abstract][Full Text] [Related]
27. Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population.
Gürlek A; Erbaş T; Sayinalp S; Gedik O
Acta Diabetol; 1996 Sep; 33(3):216-9. PubMed ID: 8904928
[TBL] [Abstract][Full Text] [Related]
28. Low hemoglobin A1c levels in a patient with diabetic ketoacidosis: Fulminant type 1 diabetes mellitus.
Keskin M; Savaş-Erdeve Ş; Çetinkaya S; Aycan Z
Turk J Pediatr; 2018; 60(2):201-205. PubMed ID: 30325130
[TBL] [Abstract][Full Text] [Related]
29. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
[TBL] [Abstract][Full Text] [Related]
30. Is Type 1 diabetes in the Japanese population the same as among Caucasians?
Kawasaki E; Eguchi K
Ann N Y Acad Sci; 2004 Dec; 1037():96-103. PubMed ID: 15699499
[TBL] [Abstract][Full Text] [Related]
31. Diabetic ketoacidosis.
Freeland BS
Diabetes Educ; 2003; 29(3):384-6, 389-92, 394-5. PubMed ID: 12854334
[No Abstract] [Full Text] [Related]
32. Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes.
Elliott J; Jacques RM; Kruger J; Campbell MJ; Amiel SA; Mansell P; Speight J; Brennan A; Heller SR
Diabet Med; 2014 Jul; 31(7):847-53. PubMed ID: 24654672
[TBL] [Abstract][Full Text] [Related]
33. [Non classical subtypes of diabetes mellitus].
Raddatz V; Durruty P; Briones G; López G; Soto N; García de los Ríos M
Rev Med Chil; 2001 Aug; 129(8):853-60. PubMed ID: 11680958
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and immunological characteristics in rapid-onset type 1 diabetes with hyperamylasemia].
Zhang C; Zhou ZG; Zhang DM; Yang XL; Zhou M; Lin J; Huang G; Wang JP
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):967-71. PubMed ID: 16061004
[TBL] [Abstract][Full Text] [Related]
35. Temporal changes in the diagnosis of type 1 diabetes by diabetic ketoacidosis in Brazil: a nationwide survey.
Negrato CA; Cobas RA; Gomes MB;
Diabet Med; 2012 Sep; 29(9):1142-7. PubMed ID: 22269058
[TBL] [Abstract][Full Text] [Related]
36. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes.
Rubio-Cabezas O; Edghill EL; Argente J; Hattersley AT
Diabet Med; 2009 Oct; 26(10):1070-4. PubMed ID: 19900242
[TBL] [Abstract][Full Text] [Related]
37. Episodes of severe hypoglycemia is associated with a progressive increase in hemoglobin A1c in children and adolescents with type 1 diabetes.
Pilgaard KA; Breinegaard N; Johannesen J; Pörksen S; Fredheim S; Madsen M; Kristensen K; Svensson J; Birkebaek NH
Pediatr Diabetes; 2020 Aug; 21(5):808-813. PubMed ID: 32304129
[TBL] [Abstract][Full Text] [Related]
38. Pancreas-kidney transplantation and the evolution of pancreatic autoantibodies.
Martins L; Malheiro J; Henriques AC; Dias L; Dores J; Oliveira F; Seca R; Almeida R; Sarmento AM; Cabrita A; Teixeira M
Transplant Proc; 2009 Apr; 41(3):913-5. PubMed ID: 19376387
[TBL] [Abstract][Full Text] [Related]
39. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
[TBL] [Abstract][Full Text] [Related]
40. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
